What is Life Science Intelligence?
Life Science Intelligence (LSI) operates as a premier Medtech market analysis firm, delivering high-fidelity market research, consulting, and proprietary intelligence software. The company serves a diverse clientele, including pharmaceutical giants and financial institutions, by providing granular data on surgical procedure volumes and emerging industry innovations. Through its comprehensive databases and high-level executive summits, LSI functions as a central hub for industry discourse, enabling organizations to navigate the intricate regulatory and commercial complexities of the global healthcare market. With nearly two decades of operational expertise, the firm has established itself as an indispensable partner for strategic decision-making in the life sciences sector.
How much funding has Life Science Intelligence raised?
Life Science Intelligence has raised a total of $5.6M across 3 funding rounds:
Debt
$72K
Debt
$2.3M
Debt
$3.2M
Debt (2021): $72K with participation from PPP
Debt (2024): $2.3M led by Meridian Bank
Debt (2026): $3.2M supported by EverBank National Association
Key Investors in Life Science Intelligence
PPP
Public-Private Partnership
Meridian Bank
A commercial banking institution providing specialized financial services and capital structures for established enterprise clients.
EverBank National Association
A national financial services provider offering comprehensive banking and lending solutions to support large-scale corporate initiatives.
What's next for Life Science Intelligence?
With the recent infusion of capital, Life Science Intelligence is well-positioned to scale its digital intelligence infrastructure and expand its global event footprint. The firm is expected to prioritize the enhancement of its surgical procedure databases and the integration of advanced predictive analytics to better serve its enterprise-level clients. As the medtech industry faces rapid technological shifts, LSI's strategic roadmap likely involves deepening its consulting capabilities to address the evolving needs of pharmaceutical and medical device manufacturers. This financial backing provides the necessary runway to accelerate product development and maintain its competitive edge in the high-stakes market intelligence arena.
See full Life Science Intelligence company page
